Table 3

Prognostic significance of K-ras mutations for the development of bile duct dysplasias and cholangiocarcinomas (CCC)

Mean follow up period (months) CCC Dysplasia Dysplasia
+ CCC
PSC with K-ras mutations (n=17)34.6426
p=0.006p=0.082p<0.001
PSC without K-ras mutations (n=39)30.2000